Financing type:  underwritten prospectus offering

Gross proceeds:  $86,273,000

Offering:   19,607,500 listed shares

Offering price:  $4.40 per listed share

Overallotment option:  The underwriters may purchase a maximum of 2,557,500 listed shares for overallotment purposes. As of Jan. 20, 2026, such option has been exercised in full and 2,557,500 listed shares have been issued thereunder. All information presented herein includes such exercise.

Public disclosure:  Refer to the prospectus supplement dated Jan. 15, 2026, and company's news releases dated Jan. 13, 2026, and Jan. 20, 2026.